FDA Inspection 1236667 — FXM Clinical Research Miramar LLC
The FDA completed an inspection of FXM Clinical Research Miramar LLC on Apr 5, 2024 in Miramar, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miramar, FL (United States)
Additional details
Clinical BA/BE